Cloning and Expression of Human Membrane-Bound and Soluble Engineered T Cell Receptors for Immunotherapy
暂无分享,去创建一个
O. Finn | N. Alajez | Nehad M. Alajez | Olivera J. Finn | Saman Eghtesad | S. Eghtesad | Saman Eghtesad
[1] M. Weijtens,et al. Functional balance between T cell chimeric receptor density and tumor associated antigen density: CTL mediated cytolysis and lymphokine production , 2000, Gene Therapy.
[2] Simon C Watkins,et al. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1. , 1998, Journal of immunology.
[3] S. Rosenberg,et al. High Efficiency TCR Gene Transfer into Primary Human Lymphocytes Affords Avid Recognition of Melanoma Tumor Antigen Glycoprotein 100 and Does Not Alter the Recognition of Autologous Melanoma Antigens , 2003, The Journal of Immunology.
[4] J W Gratama,et al. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR , 2000, Gene Therapy.
[5] Z. Eshhar,et al. The T-body approach: potential for cancer immunotherapy , 2004, Springer Seminars in Immunopathology.
[6] M. Nishimura,et al. Transfer of TCR Genes into Mature T Cells Is Accompanied by the Maintenance of Parental T Cell Avidity , 2003, The Journal of Immunology.
[7] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[8] S. Batra,et al. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct , 2000, Cancer Immunology, Immunotherapy.
[9] I. M. Belyakov,et al. Molecular mechanisms and biological significance of CTL avidity. , 2003, Current HIV research.
[10] R. Siliciano,et al. A soluble, single-chain T-cell receptor fragment endowed with antigen-combining properties. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[11] C Grégoire,et al. Covalent assembly of a soluble T cell receptor-peptide-major histocompatibility class I complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] J. Berzofsky,et al. Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. , 2001, International immunology.
[13] R. Klausner,et al. High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. , 1992, Science.
[14] M. Yáñez-Mó,et al. Cutting Edge: Dynamic Redistribution of Tetraspanin CD81 at the Central Zone of the Immune Synapse in Both T Lymphocytes and APC1 , 2002, The Journal of Immunology.
[15] G. Linette,et al. Antimelanoma Activity of CTL Generated from Peripheral Blood Mononuclear Cells After Stimulation with Autologous Dendritic Cells Pulsed with Melanoma gp100 Peptide G209-2M Is Correlated to TCR Avidity , 2002, The Journal of Immunology.
[16] N. Brouwenstijn,et al. TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning , 2002, International journal of cancer.
[17] M. Cascio,et al. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. , 2005, Blood.